wyszukanych pozycji: 3
New Therapeutic Strategies in Lung Cancers
ISBN: 9783319354095 / Angielski / Miękka / 2016 / 255 str. Termin realizacji zamówienia: ok. 10-14 dni roboczych. This book offers an up-to-date review of current management of Non Small Cell Lung Cancer. It addresses all the modern issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods.
This book offers an up-to-date review of current management of Non Small Cell Lung Cancer. It addresses all the modern issues that have been raised by...
|
|
cena:
413,31 zł |
New Therapeutic Strategies in Lung Cancers
ISBN: 9783319060613 / Angielski / Twarda / 2014 / 255 str. Termin realizacji zamówienia: ok. 20 dni roboczych. This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that have been raised by the discovery of oncogenic drivers and the improvement of diagnosis and therapeutic methods, including new radiotherapy techniques and anticancer strategies like immunotherapy. New strategies for patients with molecular alterations and the management of particular types of cases are also highlighted. Written by recognized experts in their field, the book represents a unique and valuable resource in the field of lung cancer,...
This book provides an up-to-date review of current management techniques for Non-Small Cell Lung Cancer. It addresses all of the latest issues that ha...
|
|
cena:
390,87 zł |
Fast Facts: Non-Small-Cell Lung Cancer
ISBN: 9783318070101 / Angielski / Miękka / 2022 / 146 str. Termin realizacji zamówienia: ok. 10-14 dni roboczych. Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer death in both men and women worldwide. Annual low-dose CT screening of high-risk individuals has the potential to detect early-stage tumors, which can usually be successfully treated with a combination of surgery, radiotherapy, and chemotherapy and, in some cases, targeted therapy. However, most patients with NSCLC still present with advanced or metastatic disease. For these patients, initial therapy is guided by the tumor's molecular...
Despite an overall decrease in tobacco use, lung cancer (80-85% of which is non-small-cell lung cancer [NSCLC]) is still the leading cause of cancer d...
|
|
cena:
92,96 zł |